Skip to main content
. 2021 Sep 14;35(2):173–181. doi: 10.1093/ajh/hpab143

Table 3.

Association between blood pressure variability (BPV) and eGFR trajectory for BPV (mm Hg) as a continuous variable and according to tertiles (T) of SD of systolic BP

Continuous BPV T1 T2 T3
N 16,193 5,398 5,430 5,365
Estimatea Interactionb Estimatea Interactionb Estimatea Interactionb
Model 1 −0.18
(P < 0.01)
−0.01
(P = 0.08)
REF −0.34
(P = 0.21)
0.02
(P = 0.73)
−2.23
(P < 0.01)
−0.04
(P = 0.54)
Model 2 −0.12
(P < 0.01)
−0.01
(P = 0.09)
REF −0.05
(P = 0.85)
0.02
(P = 0.75)
−1.44
(P < 0.01)
−0.04
(P = 0.55)
Model 3 −0.11
(P < 0.01)
−0.01
(P = 0.10)
REF −0.02
(P = 0.94)
0.02
(P = 0.76)
−1.29
(P < 0.01)
−0.04
(P = 0.56)
Model 4 −0.10
(P < 0.01)
−0.01
(P = 0.10)
REF 0.01
(P = 0.96)
0.02
(P = 0.76)
−1.21
(P < 0.01)
−0.04
(P = 0.56)
Model 5 −0.08
(P < 0.01)
−0.01
(P = 0.11)
REF 0.11
(P = 0.68)
0.02
(P = 0.75)
−0.90
(P < 0.01)
−0.04
(P = 0.57)

Abbreviations: BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate; REF, reference. Model 1: unadjusted. Model 2: adjusted for age and sex. Model 3: includes Model 2 adjustments and diabetes, smoking, country, aspirin, race/ethnicity, BMI, and baseline statin use. Model 4: includes Model 3 adjustments and within-individual mean systolic blood pressure from baseline to second annual visit. Model 5: includes Model 4 adjustments and baseline antihypertensive drug use.

aEstimate of the cross-sectional association of BPV with eGFR at baseline.

bTime–BPV interaction term to test variation of the eGFR trajectory among BPV levels.